APA (7th ed.) Citation

Yang, S., Ngo, L. T., Lee, S., Yun, H., Bui, T. T., Kim, D., . . . Park, S. Model-Based Evaluation of HangAmDan-B1 and Afatinib Combination Therapy in HCC827 Xenograft Mice with Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. MDPI AG.

Chicago Style (17th ed.) Citation

Yang, Sung-yoon, Lien Thi Ngo, Soyoung Lee, Hwi-yeol Yun, Tham Thi Bui, Dong-Hyeon Kim, Jung-woo Chae, and Sojung Park. Model-Based Evaluation of HangAmDan-B1 and Afatinib Combination Therapy in HCC827 Xenograft Mice with Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. MDPI AG.

MLA (9th ed.) Citation

Yang, Sung-yoon, et al. Model-Based Evaluation of HangAmDan-B1 and Afatinib Combination Therapy in HCC827 Xenograft Mice with Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. MDPI AG.